Attenuation of the serotonin-induced increase in intracellular calcium in rat aortic smooth muscle cells by sarpogrelate

Canadian Journal of Physiology and Pharmacology

Volumn 81, Issue 11, 2003, Pages 1056-1063

  Saini, Harjot K ^a   Sharma, Sushil K ^a   Zahradka, Peter ^a   Kumamoto, Hideo ^a   Takeda, Nobuakira ^b   Dhalla, Naranjan S ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Intracellular Ca 2+; Sarpogrelate; Serotonin; Vascular smooth muscle cells

Indexed keywords

CALCIUM ANTAGONIST; CINANSERIN; CYCLOPIAZONIC ACID; DILTIAZEM; KETANSERIN; METHYSERGIDE; MIANSERIN; SARPOGRELATE; SEROTONIN; SEROTONIN 2A ANTAGONIST; SEROTONIN ANTAGONIST; THAPSIGARGIN; VERAPAMIL;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR SPACE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; SMOOTH MUSCLE FIBER;

ANIMALS; AORTA; CALCIUM; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; INTRACELLULAR FLUID; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN ANTAGONISTS; SUCCINATES;

EID: 0346729712     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y03-108     Document Type: Article

References (42)

1. 1 receptors. Can. J. Physiol. Pharmacol. 81: 150-158.
2. Assender, J.W., Irenius, E., and Fredholm, B.B. 1997. 5-Hydroxytryptamine, angiotensin and bradykinin transiently increase intracellular calcium concentrations and PKC-α activity, but do not induce mitogenesis in human vascular smooth muscle cells. Acta Physiol. Scand. 160: 207-217.
3. Bhugra, P., Xu, Y.J., Rathi, S., and Dhalla, N.S. 2003. Modification of intracellular free calcium in cultured A1O vascular smooth muscle cells by exogenous phosphatidic acid. Biochem. Pharmacol. 65: 2091-2098.
4. Bonate, P.L. 1991. Serotonin receptor subtypes: functional, physiological, and clinical correlates. Clin. Neuropharmacol. 14: 1-16.
5. 2A receptor antagonist sarpogrelate. L.A. Arch. Cardiovasc. Sci. 1: 54-65.
6. Brasil, D., Temsah, R.M., Kumar, K., Kumamoto, H., Takeda, N., and Dhalla, N.S. 2002. Blockade of 5-HT2A receptors by sarpogrelate protects the heart against myocardial infarction in rats. J. Cardiovasc. Pharmacol. Ther. 7: 53-59.
7. Capponi A.M., Lew, P.D., and Vallotton, M.B. 1987. Effect of serotonin on cytosolic free calcium in adrenal glomerulosa and vascular smooth muscle cells. Eur. J. Pharmacol. 144: 53-60.
8. Chamley-Campbell, J.H., Campbell, G.R., and Ross, R. 1981. Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J. Cell. Biol. 89: 379-383.
9. Daniel, E.E., van Breemen, C., Schilling, W.P., and Kwan, C.Y. 1995. Regulation of vascular tone: cross-talk between sarcoplasmic reticulum and plasmalemma. Can. J. Physiol. Pharmacol. 73: 551-557.
10. Dickenson, J.M., Bulmer, S., Whittaker, A., Salwey, M., Hawley, J., and Hill, S.J. 1994. Bradykinin B2- and 5-hydroxytryptamine (5-HT2)-receptor stimulated increase in intracellular calcium in cultured guinea-pig aortic smooth muscle cells. Biochem. Pharmacol. 47: 947-952.
11. i protein. Cell Signal. 3: 547-557.
12. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450.
13. Hara, H., Osakabe, M., Kitajima, A., Tamao, Y., and Kikumoto, R. 1991a. MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist. Thromb. Haemostasis, 65: 415-420.
14. Hara, H., Kitajima, A., Shimada, H., and Tamao, Y. 1991b. Antithrombotic effect of MCI-9042, a new antiplatelet agent on experimental thrombosis models. Thromb. Haemostasis, 66: 484-488.
15. Hirafuji, M., Nezu, A., Kanai, Y., Ebihara, T., Kawahara, F., Tanimura, A., and Minami, M. 1998. Effect of 5-hydroxytryptamine on intracellular calcium dynamics in cultured rat vascular smooth muscle cells. Res. Commun. Mol. Pathol. Pharmacol. 99: 305-319.
16. 2+ channels by serotonin 2 receptor stimulation in vascular smooth muscle cells. Am. J. Physiol. 268: H544-H549.
17. 2+ mobility in A7r5 cultured vascular smooth muscle cells. Kaohsiung J. Med. Sci. 18: 435-442.
18. Houston, D.S., and Vanhoutte, P.M. 1986. Serotonin and the vascular system. Role in health and disease, and implications for therapy. Drugs, 31: 149-163.
19. 2+ in cultured rat mesangial cells. Life Sci. 55: PL365-PL370.
20. Kaplan-Albuquerque, N., and Di Salvo J. 1998. Protein kinase C: modulation of vasopressin-induced calcium influx and release in A7r5 vascular smooth muscle cells. Arch. Biochem. Biophys. 359: 209-214.
21. Kaumann, A.J., Parsons, A.A., and Brown, A.M. 1993. Human arterial constrictor serotonin receptors. Cardiovasc. Res. 27: 2094-2103.
22. Kornfeld, M., Salomonsson, M., Gutierrez, A., and Persson, A.E. 2000. The influence of beta-adrenergic activation on noradrenergic alpha1 activation of rabbit afferent arterioles. Pflugers Arch. 441: 25-31.
23. Lembo, P.M., and Albert, P.R. 1995. Multiple phosphorylation sites are required for pathway-selective uncoupling of the 5-hydroxytryptamine1A receptor by protein kinase C. Mol. Pharmacol. 48: 1024-1029.
24. Martin, G.R. 1994. Vascular receptors for 5-hydroxytryptamine: distribution, function and classification. Pharmacol. Ther. 62: 283-324.
25. Nelson, S.R., Chien, T., and Di Salvo, J. 1997. Genistein sensitivity of calcium transport pathways in serotonin-activated vascular smooth muscle cells. Arch. Biochem. Biophys. 345: 65-72.
26. Pawlak, D., Malyszko, J., Mysliwiec, M., Takada, A., and Buczko, W. 1996. Influence of MCI-9042, a novel 5-HT2 receptor blocker on blood vessels of the rat. Acta Physiol. Hung. 84: 323-324.
27. Rosen, B., Barg, J., and Zimlichman, R. 1999. The effects of angiotensin II, endothelin-1, and protein kinase C inhibitor on DNA synthesis and intracellular calcium mobilization in vascular smooth muscle cells from young normotensive and spontaneously hypertensive rats. Am. J. Hypertens. 12: 1243-1251.
28. Saward, L., and Zahradka, P. 1997. Coronary artery smooth muscle in culture: migration of heterogeneous cell populations from vessel wall. Mol. Cell. Biochem. 176: 53-59.
29. Schwartz, S.M., and Reidy, M.A. 1987. Common mechanisms of proliferation of smooth muscle in atherosclerosis and hypertension. Hum. Pathol. 18: 240-247.
30. Schwartz, S.M., Campbell, G.R., and Campbell, J.H. 1986. Replication of smooth muscle cells in vascular disease. Circ. Res. 58: 427-444.
31. Sharma, S.K., Zahradka, P., Chapman, D., Kumamoto, H., Takeda, N., and Dhalla, N.S. 1999. Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate. J. Pharmacol. Exp. Ther. 290: 1475-1481.
32. Sharma, S.K., Del Rizzo, D.F., Zahradka, P., Bhangu, S.K., Werner, J.P., Kumamoto, H., Takeda, N., and Dhalla, N.S. 2001. Sarpogrelate inhibits serotonin-induced proliferation of porcine coronary artery smooth muscle cells: implications for long-term graft patency. Ann. Thorac. Surg. 71: 1856-1865.
33. Sperti, G., and Colucci, W.S. 1991. Calcium influx modulates DNA synthesis and proliferation in A7r5 vascular smooth muscle cells. Eur. J. Pharmacol. 206: 279-284.
34. Sung, C.P., Arleth, A.J., and Ohlstein, E.H. 1993. Carvedilol inhibits vascular smooth muscle cell proliferation. J. Cardiovasc. Pharmacol. 21: 221-227.
35. Temsah, R.M., Kumamoto, H., Takeda, N., and Dhalla, N.S. 2001. Sarpogrelate diminishes changes in energy stores and ultrastructure of the ischemic-reperfused rat heart. Can. J. Physiol. Pharmacol. 79: 761-767.
36. Turlapaty, P.D., and Altura, B.M. 1982. Propranolol induces contractions of canine small and large coronary arteries. Basic Res. Cardiol. 77: 68-81.
37. Wang, Y., Baimbridge, K.G., and Mathers, D.A. 1991. Effect of serotonin on intracellular free calcium of rat cerebrovascular smooth muscle cells in culture. Can. J. Physiol. Pharmacol. 69: 393-399.
38. Wang, X., Dakshinamurti, K., Musat, S., and Dhalla N.S. 1999. Pyridoxal 5′-phosphate is an ATP-receptor antagonist in freshly isolated rat cardiomyocytes. J. Mol. Cell. Cardiol. 31: 1063-1072.
39. Watanabe, T., Pakala, R., Katagiri, T., and Benedict, C.R. 2001. Angiotensin II and serotonin potentiate endothelin-1-induced vascular smooth muscle cell proliferation. J. Hypertens. 19: 731-739.
40. Wolf, C., Cai, W.J., Vosschulte, R., Koltai, S., Mousavipour, D., Scholz, D., Afsah-Hedjri, A., Schaper, W., and Schaper, J. 1998. Vascular remodeling and altered protein expression during growth of coronary collateral arteries. J. Mol. Cell. Cardiol. 30: 2291-2305.
41. 2+ homeostasis in cardiomyocytes. Mol. Cell. Biochem. 172: 149-157.
42. Xu, Y.J., Rathi, S.S., Chapman, D.C., Arneja, A.S., and Dhalla, N.S. 2003. Mechanisms of lysophosphatidic acid-induced DNA synthesis in vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 41: 381-387.